John Brew
62Patents
19h-index
14Co-inventors
77Inventor score
Filing activity: Mar 9, 2007 → Oct 16, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8895536B2 | Compositions and methods for treating chronic inflammation and inflammatory diseases | Emerging Cross-Sectional Technologies | 98 | Active |
| US9308213B2 | Solid solution compositions and use in chronic inflammation | Emerging Cross-Sectional Technologies | 50 | Active |
| US8895537B2 | Compositions and methods for treating cardiovascular diseases | Emerging Cross-Sectional Technologies | 46 | Active |
| US9271950B2 | Compositions for treating chronic inflammation and inflammatory diseases | Human Necessities | 42 | Active |
| US9265742B2 | Compositions and methods for treating inflammatory pain | Emerging Cross-Sectional Technologies | 38 | Active |
| US9326958B2 | Compositions for treating chronic inflammation and inflammatory diseases | Emerging Cross-Sectional Technologies | 38 | Active |
| US9381180B2 | Compositions and methods for treating chronic inflammation and inflammatory diseases | Emerging Cross-Sectional Technologies | 38 | Active |
| US9504664B2 | Compositions and methods for treating severe pain | Human Necessities | 32 | Active |
| US9427422B2 | Compositions for treating cardiovascular diseases | Emerging Cross-Sectional Technologies | 32 | Active |
| US9737500B2 | Compositions and methods for treating severe pain | Human Necessities | 31 | Active |
| US9795577B2 | Compositions and methods for treating severe pain | Human Necessities | 31 | Active |
| US9827215B2 | Solid solution compositions and use in chronic inflammation | Emerging Cross-Sectional Technologies | 29 | Active |
| US9789075B2 | Compositions and methods for treating cardiovascular diseases | Emerging Cross-Sectional Technologies | 29 | Active |
| US9775820B2 | Solid solution compositions and use in chronic inflammation | Emerging Cross-Sectional Technologies | 29 | Active |
| US9820952B2 | Solid solution compositions and use in chronic inflammation | Emerging Cross-Sectional Technologies | 29 | Active |
| US9744132B2 | Solid solution compositions and use in chronic inflammation | Human Necessities | 29 | Active |
| US9750810B2 | Compositions and methods for treating chronic inflammation and inflammatory diseases | Human Necessities | 29 | Active |
| US9693980B2 | Compositions and methods for treating chronic inflammation and inflammatory diseases | Emerging Cross-Sectional Technologies | 29 | Active |
| US10004704B2 | Compositions and methods for treating chronic inflammation and inflammatory diseases | Emerging Cross-Sectional Technologies | 19 | Active |
| US10231943B2 | Compositions and methods for treating cardiovascular diseases | Emerging Cross-Sectional Technologies | 18 | Active |
| US10143671B2 | Solid solution compositions and use in chronic inflammation | Emerging Cross-Sectional Technologies | 18 | Active |
| US10363232B2 | Compositions and methods for treating severe pain | Human Necessities | 18 | Active |
| US10154975B2 | Solid solution compositions and use in chronic inflammation | Emerging Cross-Sectional Technologies | 18 | Active |
| US10155042B2 | Compositions and methods for treating chronic inflammation and inflammatory diseases | Human Necessities | 18 | Active |
| US10213381B2 | Solid solution compositions and use in chronic inflammation | Human Necessities | 18 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.